Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBT Margin (2023 - 2025)

Historic EBT Margin for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to 29.0%.

  • Astera Labs' EBT Margin rose 272200.0% to 29.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.74%, marking a year-over-year increase of 474900.0%. This contributed to the annual value of 20.64% for FY2024, which is 8200.0% down from last year.
  • Astera Labs' EBT Margin amounted to 29.0% in Q3 2025, which was up 272200.0% from 26.4% recorded in Q2 2025.
  • In the past 5 years, Astera Labs' EBT Margin registered a high of 29.0% during Q3 2025, and its lowest value of 150.24% during Q2 2023.
  • For the 3-year period, Astera Labs' EBT Margin averaged around 26.46%, with its median value being 1.78% (2024).
  • As far as peak fluctuations go, Astera Labs' EBT Margin tumbled by -251100bps in 2024, and later surged by 1368400bps in 2025.
  • Over the past 3 years, Astera Labs' EBT Margin (Quarter) stood at 21.17% in 2023, then tumbled by -64bps to 7.58% in 2024, then skyrocketed by 282bps to 29.0% in 2025.
  • Its last three reported values are 29.0% in Q3 2025, 26.4% for Q2 2025, and 13.62% during Q1 2025.